Vascular Ehlers-danlos Syndrome
📧 Sign up to get email alerts when something new happens for Vascular Ehlers-danlos Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-03-08Clinical Trial Update: Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome. [Phase 3]
A Phase 3 trial evaluating enzastaurin for arterial event prevention in vascular Ehlers-Danlos syndrome is suspended.